8C7 mAb (Monash University)

N/A

Report date: 2025/01/26 19:27:55

Base Information

Drug Name8C7 mAb (Monash University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 10 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 10
Therapy Area/IndicationsHematologic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer CenterMonash University
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A